Top experts by indication / Oncology
Most active experts in Hodgkin Disease
2026 edition, data as of October 27, 2026
298 key opinion leaders in the directory are tagged to Hodgkin Disease. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 298 of the 298 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Ajay GopalUniversity of Washington School of Medicine, WA | 17 trials |
| 2 | Alex HerreraCity of Hope, CA | 14 trials |
| 3 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 12 trials |
| 4 | Anas YounesNY | 11 trials |
| 5 | Mitchell CairoNew York Medical College, NY | 10 trials |
| 6 | Ryotaro NakamuraCity of Hope, CA | 9 trials |
| 7 | Alison MoskowitzMemorial Sloan Kettering Cancer Center, NY | 9 trials |
| 8 | Helen HeslopBaylor College of Medicine, TX | 8 trials |
| 9 | Julie VoseUniversity of Nebraska Medical Center, NE | 7 trials |
| 10 | David MaloneyFred Hutchinson Cancer Center, WA | 7 trials |
| 11 | Thomas WitzigMayo Clinic, MN | 7 trials |
| 12 | Veronika BachanovaUniversity of Minnesota Medical School, MN | 6 trials |
| 13 | Jeremy AbramsonMassachusetts General Hospital, MA | 6 trials |
| 14 | Neal FlomenbergThomas Jefferson University, PA | 5 trials |
| 15 | Brandon TriplettSt. Jude Children's Research Hospital, TN | 5 trials |
| 16 | Nancy BartlettWashington University School of Medicine, MO | 5 trials |
| 17 | Ranjana AdvaniStanford University School of Medicine, CA | 5 trials |
| 18 | Catherine DiefenbachNYU Langone Health, NY | 5 trials |
| 19 | David AviganDana-Farber Cancer Institute, MA | 5 trials |
| 20 | Stephen AnsellMayo Clinic, MN | 4 trials |
| 21 | Owen O'ConnorNY | 4 trials |
| 22 | Nirav ShahWI | 4 trials |
| 23 | Claudio BrunsteinMN | 4 trials |
| 24 | Jane WinterIL | 4 trials |
| 25 | Grzegorz NowakowskiMayo Clinic, MN | 4 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 88 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 2 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 3 | Thomas WitzigMayo Clinic, MN | 62,686 citations |
| 4 | Julie VoseUniversity of Nebraska Medical Center, NE | 59,133 citations |
| 5 | Malcolm BrennerBaylor College of Medicine, TX | 59,020 citations |
| 6 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 7 | Ian FlinnTennessee Oncology, TN | 55,739 citations |
| 8 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
| 9 | Stephen AnsellMayo Clinic, MN | 52,585 citations |
| 10 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 50,317 citations |
| 11 | Bruce ChesonThe Center for Cancer and Blood Disorders, MD | 49,627 citations |
| 12 | Ranjana AdvaniStanford University School of Medicine, CA | 48,943 citations |
| 13 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 48,319 citations |
| 14 | Nancy BartlettWashington University School of Medicine, MO | 48,210 citations |
| 15 | Helen HeslopBaylor College of Medicine, TX | 43,332 citations |
| 16 | Corey CutlerDana-Farber Cancer Institute, MA | 42,105 citations |
| 17 | Yi LinMayo Clinic, MN | 40,137 citations |
| 18 | Philippe ArmandMayo Clinic, MN | 38,160 citations |
| 19 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 36,879 citations |
| 20 | Joanne KurtzbergDuke University Medical Center, NC | 35,382 citations |
| 21 | Patricia LorussoYale School of Medicine, MI | 34,992 citations |
| 22 | Stephen SchusterUniversity of Pennsylvania, PA | 33,743 citations |
| 23 | John LeonardNYU Langone Health, NY | 32,192 citations |
| 24 | Ronald GressNational Cancer Institute (NIH), MD | 31,095 citations |
| 25 | Jason WestinThe University of Texas MD Anderson Cancer Center, TX | 30,280 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 75 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Ronald LevyCA | 22 awards |
| 2 | Richard AmbinderJohns Hopkins University School of Medicine, MD | 19 awards |
| 3 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 4 | Edmund WallerEmory University, GA | 13 awards |
| 5 | Malcolm BrennerBaylor College of Medicine, TX | 12 awards |
| 6 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 7 | Helen HeslopBaylor College of Medicine, TX | 9 awards |
| 8 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 9 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 10 | Carl AllenTX | 7 awards |
| 11 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 12 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 13 | Jennifer WoyachThe Ohio State University, OH | 7 awards |
| 14 | Joanne KurtzbergDuke University Medical Center, NC | 7 awards |
| 15 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 6 awards |
| 16 | Lawrence KaplanSan Francisco General Hospital, CA | 6 awards |
| 17 | Saro ArmenianCity of Hope, CA | 6 awards |
| 18 | Thomas WitzigMayo Clinic, MN | 6 awards |
| 19 | Nancy BartlettWashington University School of Medicine, MO | 5 awards |
| 20 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 5 awards |
| 21 | Ajay GopalUniversity of Washington School of Medicine, WA | 5 awards |
| 22 | Yi LinMayo Clinic, MN | 5 awards |
| 23 | Stephen AnsellMayo Clinic, MN | 4 awards |
| 24 | David McDermottBeth Israel Deaconess Medical Center, MA | 4 awards |
| 25 | Sandra HorningCA | 4 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 57 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 2 | Ian FlinnTennessee Oncology, TN | 242 contributions |
| 3 | Thomas WitzigMayo Clinic, MN | 240 contributions |
| 4 | Yi LinMayo Clinic, MN | 226 contributions |
| 5 | Stephen SchusterUniversity of Pennsylvania, PA | 224 contributions |
| 6 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 7 | Brad KahlWashington University School of Medicine in St. Louis, MO | 208 contributions |
| 8 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 202 contributions |
| 9 | Mazyar ShadmanFred Hutchinson Cancer Center, WA | 199 contributions |
| 10 | Jason WestinThe University of Texas MD Anderson Cancer Center, TX | 198 contributions |
| 11 | Jennifer WoyachThe Ohio State University, OH | 176 contributions |
| 12 | John DipersioWashington University School of Medicine, MO | 171 contributions |
| 13 | Jonathon CohenEmory University, GA | 169 contributions |
| 14 | Ranjana AdvaniStanford University School of Medicine, CA | 160 contributions |
| 15 | John LeonardNYU Langone Health, NY | 159 contributions |
| 16 | Ibrahim AldossCity of Hope, CA | 151 contributions |
| 17 | Paolo CaimiCleveland Clinic, OH | 139 contributions |
| 18 | Alison MoskowitzMemorial Sloan Kettering Cancer Center, NY | 137 contributions |
| 19 | Geoffrey UyWashington University School of Medicine, MO | 130 contributions |
| 20 | David MaloneyFred Hutchinson Cancer Center, WA | 127 contributions |
| 21 | Ryotaro NakamuraCity of Hope, CA | 125 contributions |
| 22 | Edmund WallerEmory University, GA | 121 contributions |
| 23 | Julie VoseUniversity of Nebraska Medical Center, NE | 115 contributions |
| 24 | Kami MaddocksThe Ohio State University, OH | 111 contributions |
| 25 | Philippe ArmandMayo Clinic, MN | 111 contributions |
Emerging
6 of the 298 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Rafael BejarUniversity of California, San Diego, CA |
| Sharon CastellinoEmory University, GA |
| Douglas HawkinsSeattle Children's Hospital, WA |
| Bilal OmerBaylor College of Medicine, TX |
| Sandra SilbermanNC |
| Dan VoglUniversity of Pennsylvania, PA |
How these tables are computed
The cohort is every profile in the directory tagged to Hodgkin Disease, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Hodgkin Disease profile in the directory